Selskap · org.nr 816823862
Full tilgang →
ZELLUNA IMMUNOTHERAPY AS
Største aksjonærer
| Aksjonær | Sted | Aksjer | Andel |
|---|---|---|---|
| ZELLUNA ASA | OSLO | 13 524 826 | 100.0 % |
Endringer 2024 → 2025
| Aksjonær | 2024 | 2025 | Endring |
|---|---|---|---|
| ZELLUNA ASA Ny | — | 13 524 826 | +13 524 826 |
| RADFORSK INVESTERINGSSTIFTELSE Ute | 1 834 205 | — | −1 834 205 |
| GEVERAN TRADING COMPANY LTD Ute | 1 725 845 | — | −1 725 845 |
| INVEN2 AS Ute | 1 602 500 | — | −1 602 500 |
| BIRK VENTURE AS Ute | 1 175 253 | — | −1 175 253 |
| MERRILL LYNCH, PIERCE, FENNER & SM Ute | 1 025 641 | — | −1 025 641 |
| RO INVEST AS Ute | 528 196 | — | −528 196 |
| HELENE SUNDT AS Ute | 511 113 | — | −511 113 |
| CGS HOLDING AS Ute | 419 539 | — | −419 539 |
| UBS SWITZERLAND AG Ute | 339 472 | — | −339 472 |
| SIX SIS AG Ute | 334 944 | — | −334 944 |
| J.P. MORGAN SE Ute | 267 955 | — | −267 955 |
| MP PENSJON PK Ute | 248 303 | — | −248 303 |
| MYRLID AS Ute | 239 701 | — | −239 701 |
| NORDA ASA Ute | 230 028 | — | −230 028 |
| UBS SWITZERLAND AG Ute | 223 305 | — | −223 305 |
| KVANTIA AS Ute | 211 813 | — | −211 813 |
| ST CATHERINE'S COLLEGE IN THE Ute | 159 499 | — | −159 499 |
| STAVERN HELSE OG FORVALTNING AS Ute | 125 000 | — | −125 000 |
| JANDERSEN KAPITAL AS Ute | 119 850 | — | −119 850 |
| MUST INVEST AS Ute | 108 100 | — | −108 100 |
| JAKOB HATTELAND HOLDING AS Ute | 95 341 | — | −95 341 |
| HSBC BANK PLC Ute | 91 384 | — | −91 384 |
| GEC HOLDING AS Ute | 83 935 | — | −83 935 |
| PRIETA AS Ute | 60 780 | — | −60 780 |
| THE BANK OF NEW YORK MELLON Ute | 60 000 | — | −60 000 |
| TRACK AS Ute | 57 020 | — | −57 020 |
| GUNNAR KVALHEIM AS Ute | 50 000 | — | −50 000 |
| JAHATT AS Ute | 44 953 | — | −44 953 |
| H5 VEKST AS Ute | 40 000 | — | −40 000 |
Hele bildet av ZELLUNA IMMUNOTHERAPY AS
Indirekte eierskap gjennom eierkjeder, datterselskaper, regnskapstall og AI-drevet investoranalyse — i HelpAdmin.